Workflow
TKGF(601233)
icon
Search documents
桐昆股份:预计2025年度净利润同比增长62.24%至78.88%
Zheng Quan Ri Bao· 2026-01-29 14:13
Core Viewpoint - Tongkun Co., Ltd. expects to achieve a net profit attributable to shareholders of the listed company between 1.95 billion yuan and 2.15 billion yuan for the fiscal year 2025, representing an increase of 748.0964 million yuan to 948.0964 million yuan compared to the previous year, which corresponds to a growth rate of 62.24% to 78.88% [2] Financial Performance - The projected net profit for 2025 is estimated to be between 1.95 billion yuan and 2.15 billion yuan [2] - This represents an increase of 748.0964 million yuan to 948.0964 million yuan compared to the previous year's performance [2] - The anticipated growth rate is between 62.24% and 78.88% year-on-year [2]
晚间公告|1月29日这些公告有看头
Di Yi Cai Jing· 2026-01-29 10:34
Group 1 - Meinian Health plans to participate in the restructuring of Zhejiang Bangjie Holdings, aiming to become the controlling shareholder after the completion of the restructuring [3] - Baiyin Nonferrous Metals reported that the revenue from gold and silver products accounted for a low proportion of total operating income, with gold sales contributing 18.67% and silver sales 4.54% in the first half of 2025 [4] - Tiens Wind Power decided to implement a long-term production suspension for six wholly-owned subsidiaries to optimize resource allocation and focus on core businesses [5] Group 2 - Tongling Nonferrous Metals indicated significant uncertainty in the price fluctuations of its main products, with a low self-sufficiency rate for copper concentrate posing supply stability risks [6] - *ST Aowei received a notice of termination of listing due to its market capitalization falling below 500 million yuan for twenty consecutive trading days [7] - Foton Motor expects a net profit increase of approximately 1551% year-on-year for 2025, driven by sales growth in new energy vehicles and overseas markets [9] Group 3 - Beimo High-tech anticipates a net profit increase of 1076.16% to 1261.87% for 2025, supported by cost control and reduced credit impairment losses [10] - Zhongke Sanhuan forecasts a net profit growth of 566.23% to 899.35% for 2025, attributed to technological innovation and improved operational efficiency [12] - Wancheng Group expects a net profit increase of 222.38% to 266.94% for 2025, driven by growth in its retail business and improved sales margins [13] Group 4 - Huayi Technology anticipates a net profit increase of 191.52% to 330.34% for 2025, benefiting from product optimization and cost reduction measures [14] - Nanmo Biology expects a net profit growth of 269.49% to 423.44% for 2025, supported by increased revenue in the biopharmaceutical sector and improved cost control [15] - Baiao Saitu forecasts a net profit increase of 384.26% to 443.88% for 2025, driven by expansion in overseas markets and recovery in the domestic biopharmaceutical industry [16] Group 5 - Hailanxin expects a net profit increase of 387.47% to 631.2% for 2025, supported by advancements in technology and increased market share in marine observation [17] - Panjiang Co. anticipates a net profit growth of 205.3% to 264.83% for 2025, driven by increased coal production and reduced costs [18] - Huaguang New Materials expects a net profit increase of 104.67% to 141.88% for 2025, with significant growth in the electronic sector [20] Group 6 - Guo Sheng Securities forecasts a net profit increase of 25.44% to 67.25% for 2025, supported by active capital market participation and growth in various business segments [25] - Shengyi Technology expects a net profit growth of 87% to 98% for 2025, driven by increased sales of copper-clad laminates [26] - Sifutian anticipates a net loss of 30 million to 45 million yuan for 2025, although this represents a significant reduction in losses compared to the previous year [27] Group 7 - Maanshan Steel expects a net loss of 1.9 billion to 2.5 billion yuan for 2025, with a substantial reduction in losses compared to the previous year [28] - Shennong Seed Industry forecasts a net profit of 90 million to 120 million yuan for 2025, marking a turnaround from previous losses [30] - Jifeng Co. anticipates a net profit of 410 million to 495 million yuan for 2025, achieving a turnaround from losses [31]
桐昆股份发预增,预计2025年度归母净利润同比增幅62.24%至78.88%
Zhi Tong Cai Jing· 2026-01-29 10:29
桐昆股份(601233)(601233.SH)发布2025年年度业绩预增公告,预计2025年度实现归属于上市公司股 东的净利润19.5亿元至21.5亿元,与上年同期相比增加74,809.64万元至94,809.64万元,增幅62.24%至 78.88%。 2025年国内政策精准发力,直接推动涤纶长丝行业产能投放收缩,行业供需格局优化带动单吨盈利水平 显著抬升。尽管上游PTA环节亏损规模较上年进一步扩大,对产业链利润形成一定侵蚀,但在此背景 下,公司主业依然凭借长丝业务的盈利增长实现了经营利润的显著改善;另一方面公司参股的浙石化依 托全球特大型炼化一体化装置,持续优化装置性能,不断挖潜增效,化工产品线不断延伸,品种日益丰 富,部分化工产品毛利有改善。 ...
桐昆股份(601233.SH)发预增,预计2025年度归母净利润同比增幅62.24%至78.88%
智通财经网· 2026-01-29 10:29
Core Viewpoint - Tongkun Co., Ltd. (601233.SH) expects a significant increase in net profit for the year 2025, projecting a range of 1.95 billion to 2.15 billion yuan, representing a year-on-year increase of 748.1 million to 948.1 million yuan, with a growth rate of 62.24% to 78.88% [1] Group 1: Company Performance - The company anticipates a notable improvement in operating profit driven by the growth in its filament business, despite the expanded losses in the upstream PTA segment [1] - The projected net profit for 2025 indicates a strong recovery and growth trajectory for the company, reflecting effective management and operational strategies [1] Group 2: Industry Context - The polyester filament industry is experiencing a contraction in capacity due to targeted domestic policies, leading to an optimized supply-demand balance and a significant increase in profit per ton [1] - The company’s stake in Zhejiang Petrochemical is contributing positively, as the facility continues to enhance performance and expand its chemical product line, resulting in improved margins for certain chemical products [1]
1月29日晚间重要公告一览
Xi Niu Cai Jing· 2026-01-29 10:13
Earnings Forecasts - Shengyi Electronics expects a net profit of 1.431 billion to 1.513 billion yuan in 2025, an increase of 331.03% to 355.88% year-on-year [1] - Tigermed anticipates a net profit of 830 million to 1.23 billion yuan in 2025, representing a growth of 105% to 204% year-on-year [2] - Shunbo Alloy forecasts a net profit of 210 million to 270 million yuan in 2025, with an increase of 222.96% to 315.23% year-on-year [3] - Jinkong Electric expects a net profit of 155 million to 195 million yuan in 2025, reflecting a growth of 383.21% to 507.9% year-on-year [9] - Baiao Saitu anticipates a net profit of 162 million to 182 million yuan in 2025, with a year-on-year increase of 384.26% to 443.88% [18] - Panjiang Co. expects a net profit of 318 million to 380 million yuan in 2025, representing a growth of 205.30% to 264.83% year-on-year [38] Loss Forecasts - Liaoning Energy predicts a net loss of 273 million to 410 million yuan in 2025, compared to a profit of 202 million yuan in the previous year [5] - Anbotong anticipates a net loss of 114 million to 165 million yuan in 2025, with a revenue decrease of 19.65% to 27.25% [7] - Wantai Bio forecasts a net loss of 330 million to 410 million yuan in 2025, compared to a profit of 106 million yuan in the previous year [12] - Xingyun Co. expects a net loss of 155 million to 230 million yuan in 2025, compared to a loss of 82.44 million yuan in the previous year [20] - Huaxing Co. anticipates a net loss of 800 million to 1.2 billion yuan in 2025, with a reduction in loss compared to 1.67 billion yuan in the previous year [46] New Product Approvals - Hengrui Medicine received acceptance for a new indication application for its innovative drug, combining Carrelizumab and Apatinib for treating unresectable liver cancer [4] - Tianen Kang's subsidiary received a drug registration acceptance notice for Lidocaine and Prilocaine aerosol [31] - Lisheng Pharmaceutical announced that its Aminophylline tablets passed the consistency evaluation for generic drugs [40] Share Buyback Plans - Hengyuan Coal Power plans to repurchase shares with a total amount not less than 200 million yuan and not exceeding 250 million yuan [13] Contract Wins - China Communication Signal Co. won contracts totaling approximately 5.26 billion yuan for 21 important projects in the railway and urban rail transit markets [37]
桐昆股份:预计2025年年度净利润为19.5亿元至21.5亿元
Mei Ri Jing Ji Xin Wen· 2026-01-29 08:37
(记者 王瀚黎) 每经头条(nbdtoutiao)——水贝黄金平台"杰我睿"兑付危机调查:40倍杠杆对赌,金价越涨平台越 亏!老板自称"还在深圳",投资者:兑付方案本金打两折,无法接受 每经AI快讯,桐昆股份1月29日晚间发布业绩预告,预计2025年度实现归属于上市公司股东的净利润 19.5亿元至21.5亿元,与上年同期相比增加约7.48亿元至约9.48亿元,增幅62.24%~78.88%。预计公司 2025年度归属于上市公司股东扣除对联营企业和合营企业的投资收益部分的净利润9.1亿元至11.1亿元, 与上年同期相比增加约4.19亿元至约6.19亿元,增幅为85.34%~126.08%。业绩变动主要原因是,主营业 务影响。2025年国内政策精准发力,直接推动涤纶长丝行业产能投放收缩,行业供需格局优化带动单吨 盈利水平显著抬升。尽管上游PTA环节亏损规模较上年进一步扩大,对产业链利润形成一定侵蚀,但在 此背景下,公司主业依然凭借长丝业务的盈利增长实现了经营利润的显著改善;另一方面公司参股的浙 石化依托全球特大型炼化一体化装置,持续优化装置性能,不断挖潜增效,化工产品线不断延伸,品种 日益丰富,部分化工产品毛利有 ...
桐昆股份(601233) - 2025 Q4 - 年度业绩预告
2026-01-29 08:20
股票代码:601233 股票简称:桐昆股份 公告编号:2026-007 桐昆集团股份有限公司 2025年年度业绩预增公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 1、本业绩预告适用于实现盈利,且净利润与上年同期相比上升 50%以上情形。 2、经桐昆集团股份有限公司(以下简称"公司")财务部门初 步 测 算 , 预 计 2025 年 度 实 现 归 属 于 上 市 公 司 股 东 的 净 利 润 195,000.00万元至215,000.00万元,与上年同期相比增加74,809.64 万元至 94,809.64 万元,增幅 62.24%至 78.88%。 3、预计公司 2025 年度归属于上市公司股东的扣除非经常性损益 的净利润 150,000.00 万元至 170,000.00 万元,与上年同期相比增加 56,573.99 万元至 76,573.99 万元,增幅 60.55%至 81.96%。 1 (二)业绩预告情况 1、经公司财务部门初步测算,预计 2025 年度实现归属于上市公 司股东的净利润 195 ...
桐昆股份:2025年净利同比预增62.24%-78.88%
Mei Ri Jing Ji Xin Wen· 2026-01-29 08:10
每经AI快讯,1月29日,桐昆股份(601233)(601233.SH)公告称,桐昆股份预计2025年度归属于上市公 司股东的净利润为19.50亿元至21.50亿元,与上年同期相比增长62.24%至78.88%。主要因涤纶长丝行业 供需格局优化带动单吨盈利提升,叠加参股浙石化持续挖潜增效、部分化工产品毛利改善;同时政府补 助等非经常性损益金额较大。 ...
桐昆股份:2025年全年净利润同比预增62.24%—78.88%
南财智讯1月29日电,桐昆股份公告,预计2025年全年归属于上市公司股东的净利润为19.50亿元—21.50 亿元,同比预增62.24%—78.88%;预计2025年全年归属于上市公司股东的扣除非经常性损益的净利润 为15.00亿元—17.00亿元,同比预增60.55%—81.96%;主要变动原因为:2025年国内政策精准发力,直 接推动涤纶长丝行业产能投放收缩,行业供需格局优化带动单吨盈利水平显著抬升。尽管上游PTA环节 亏损规模较上年进一步扩大,对产业链利润形成一定侵蚀,但在此背景下,公司主业依然凭借长丝业务 的盈利增长实现了经营利润的显著改善;另一方面公司参股的浙石化依托全球特大型炼化一体化装置, 持续优化装置性能,不断挖潜增效,化工产品线不断延伸,品种日益丰富,部分化工产品毛利有改善; 报告期内,公司收到的政府补助、非流动资产处置损益等非经常性损益,因金额较大,对公司的净利润 构成较大影响。 ...
政策利好+周期反转!化工ETF(516020)再涨2.48%创近3年新高,周期拐点已至?
Xin Lang Cai Jing· 2026-01-28 13:53
1月28日,化工板块攻势不减。反映化工板块整体走势的化工ETF(516020)开盘短暂震荡后迅速拉 升,而后持续高位震荡,盘中场内价格最高涨幅达到3.2%,截至收盘,涨2.48%,收盘价续创2022年7 月以来新高。值得注意的是,化工ETF(516020)午后频现溢价交易,收盘溢价率更是高达0.42%,反 映买盘资金较为强势。 成份股方面,纯碱、氨纶、氮肥等板块部分个股涨幅居前。截至收盘,和邦生物、浙江龙盛双双涨停, 卫星化学、华峰化学飙涨超8%,鲁西化工、桐昆股份、宝丰能源等亦涨幅居前。 消息面上,近日,工业和信息化部、国家发改委等五部门联合印发《关于开展零碳工厂建设工作的指导 意见》。自2026年起,遴选一批零碳工厂,做好标杆引领;到2027年,在汽车、锂电池、光伏、电子电 器、轻工、机械、算力设施等行业领域,培育建设一批零碳工厂;到2030年,逐步扩展至钢铁、有色金 属、石化化工、建材、纺织等行业领域,探索传统高载能产业脱碳新路径。 方正证券指出,对化企而言,一方面未来部分高能耗或高碳排放子行业的供给侧增量存量均有政策约 束,另一方面,随着碳排放权交易市场的扩围,碳配额制度有望重塑部分行业成本曲线,加速 ...